+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Blood Plasma Derivatives Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blood Plasma Derivatives Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
From
Bleeding Disorders Treatment Market Report 2026 - Product Thumbnail Image

Bleeding Disorders Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Blood Plasma Derivatives Market Report 2026 - Product Thumbnail Image

Blood Plasma Derivatives Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Thalassemia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Thalassemia Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
From
From
Human Fibrin Sealant Kit Market - Global Forecast 2025-2030 - Product Thumbnail Image

Human Fibrin Sealant Kit Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
From
From
From
Plasma-Derived Medicines Market - Global Strategic Business Report - Product Thumbnail Image

Plasma-Derived Medicines Market - Global Strategic Business Report

  • Report
  • September 2026
  • 391 Pages
  • Global
From
From
Loading Indicator